Tags: Chemical Compound, Chemical Substance.

Levormeloxifene is an experimental selective estrogen receptor modulator that was being developed as an alternative to estrogen replacement therapy for the treatment and prevention of postmenopausal bone loss. The development was stopped because of a high incidence of gynaecologic adverse events during clinical trials. It is the enantiomer of ormeloxifene.

Levormeloxifene.svg
IUPAC name
1-(2-4-[(3R4R)-7-methoxy-22-dimethyl-3-phenyl-34-dihydro-2H-chromen-4-yl]phenoxyethyl)pyrrolidine

Loading...

This page contains content from the copyrighted Wikipedia article "Levormeloxifene"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.